7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2017-01-31 2016-10-31 2016-07-31 2016-04-30 2016-01-31 2015-10-31 2015-07-31 2015-04-30 2015-01-31 
      
    		                                           
      cash flows from operating activities:
    		                                           
      net income
    		191,000,000 257,000,000 169,000,000 -73,000,000 389,000,000 126,000,000 172,000,000 226,000,000 288,000,000 283,000,000 260,000,000 299,000,000 338,000,000 258,000,000 229,000,000 282,000,000 254,000,000 186,000,000 172,000,000 217,000,000 176,000,000 71,000,000 163,000,000 195,000,000 159,000,000 153,000,000 114,000,000 -114,000,000 121,000,000 64,000,000 94,000,000 -38,000,000 -18,000,000 49,000,000 109,000,000 92,000,000 91,000,000 88,000,000 64,000,000 277,000,000 70,000,000 96,000,000 70,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                           
      depreciation
    		33,000,000 33,000,000 31,000,000 32,000,000 32,000,000 32,000,000 30,000,000 30,000,000 31,000,000 30,000,000 29,000,000 29,000,000 29,000,000 29,000,000 30,000,000 30,000,000 30,000,000 29,000,000 28,000,000 28,000,000 26,000,000 26,000,000 24,000,000 24,000,000 24,000,000 24,000,000 24,000,000 25,000,000                
      amortization
    		34,000,000 35,000,000 35,000,000 36,000,000 32,000,000 38,000,000 38,000,000 20,000,000 23,000,000 25,000,000 24,000,000 26,000,000 27,000,000 26,000,000 27,000,000 27,000,000 34,000,000 56,000,000 59,000,000 59,000,000 54,000,000 53,000,000 56,000,000 55,000,000 54,000,000 51,000,000 52,000,000 52,000,000                
      share-based compensation
    		31,000,000 36,000,000 62,000,000 26,000,000 29,000,000 34,000,000 48,000,000 25,000,000 26,000,000 30,000,000 54,000,000 23,000,000 25,000,000 27,000,000 50,000,000 20,000,000 19,000,000 21,000,000 43,000,000 20,000,000 18,000,000 15,000,000 39,000,000 16,000,000 16,000,000 23,000,000 27,000,000 11,000,000 14,000,000 15,000,000 19,000,000 12,000,000 13,000,000 13,000,000 18,000,000 10,000,000 10,000,000 13,000,000 16,000,000 6,000,000 7,000,000 13,000,000 29,000,000 
      deferred tax expense
    		-18,000,000 -30,000,000 -10,000,000 289,000,000 -12,000,000 -15,000,000 6,000,000 -13,000,000 12,000,000 -1,000,000 -1,000,000 -12,000,000 6,000,000 4,000,000 9,000,000 -4,000,000 -31,000,000 -19,000,000 1,000,000 34,000,000 -20,000,000 9,000,000 18,000,000        -235,000,000             
      excess and obsolete inventory-related charges
    		8,000,000 13,000,000 9,000,000 9,000,000 8,000,000 10,000,000 8,000,000 8,000,000 6,000,000 7,000,000 6,000,000 9,000,000 5,000,000 7,000,000 6,000,000 7,000,000 6,000,000 7,000,000 7,000,000 8,000,000 9,000,000 5,000,000 7,000,000  7,000,000 6,000,000 7,000,000  9,000,000 5,000,000 6,000,000             
      unrealized gain on equity and other investments
    		-16,000,000 14,000,000 -37,000,000    -4,000,000  -11,000,000 1,000,000 -6,000,000                                 
      other non-cash expenses (income)
    		3,000,000 1,000,000 1,000,000                                    2,000,000 12,000,000    
      changes in assets and liabilities, net of effects of businesses acquired:
    		                                           
      accounts receivable
    		50,000,000 70,000,000 53,000,000 -59,000,000 9,000,000 -3,000,000 124,000,000 -18,000,000 -29,000,000 55,000,000 6,000,000 -38,000,000 -82,000,000 -109,000,000 25,000,000 -58,000,000 -3,000,000 -23,000,000 -38,000,000 -37,000,000 -66,000,000 181,000,000 -3,000,000 -51,000,000 53,000,000 -84,000,000 56,000,000 -34,000,000 -24,000,000 -130,000,000 99,000,000 -25,000,000 4,000,000 -30,000,000 40,000,000 -26,000,000 -13,000,000 -36,000,000 33,000,000 -51,000,000 36,000,000 -41,000,000 36,000,000 
      inventory
    		-3,000,000 8,000,000 -26,000,000 2,000,000 -1,000,000 -8,000,000 -42,000,000 -22,000,000 -33,000,000 -49,000,000 -44,000,000 -37,000,000 -34,000,000 -22,000,000 -32,000,000 -13,000,000 -7,000,000   18,000,000 -28,000,000 -27,000,000 -36,000,000 -14,000,000 -25,000,000 -27,000,000 -26,000,000 -18,000,000 -25,000,000 2,000,000 -20,000,000 -14,000,000 20,000,000 0 -10,000,000 1,000,000 -12,000,000 -7,000,000 -4,000,000 0 -8,000,000 -8,000,000 -9,000,000 
      accounts payable
    		22,000,000 23,000,000 -16,000,000 30,000,000 7,000,000 -12,000,000 1,000,000 -8,000,000 -13,000,000 -22,000,000 -19,000,000 15,000,000 10,000,000 35,000,000 -4,000,000 43,000,000 -8,000,000 14,000,000 4,000,000 27,000,000 7,000,000 -41,000,000 -26,000,000 3,000,000 9,000,000 11,000,000 -10,000,000 9,000,000 -7,000,000 6,000,000 14,000,000 32,000,000 0 -5,000,000 -12,000,000 30,000,000 -11,000,000 -5,000,000 -22,000,000 17,000,000 0 14,000,000 -13,000,000 
      employee compensation and benefits
    		-28,000,000 58,000,000 -38,000,000 33,000,000 -43,000,000 48,000,000 -74,000,000 44,000,000 -52,000,000 49,000,000 -84,000,000 64,000,000 -40,000,000 76,000,000 -117,000,000 62,000,000 -63,000,000 105,000,000 -54,000,000 59,000,000 -21,000,000 27,000,000 -63,000,000  -60,000,000 73,000,000 -68,000,000 65,000,000 -25,000,000 73,000,000 -50,000,000 32,000,000   -36,000,000 15,000,000 -10,000,000 40,000,000 -29,000,000 24,000,000 -25,000,000 29,000,000 -22,000,000 
      deferred revenue
    		-64,000,000 9,000,000 43,000,000 23,000,000 -49,000,000 -13,000,000 27,000,000 20,000,000 -40,000,000 19,000,000 62,000,000 10,000,000 -21,000,000 62,000,000 28,000,000 10,000,000 -3,000,000 39,000,000 50,000,000 6,000,000 -16,000,000 22,000,000 29,000,000 9,000,000 18,000,000 42,000,000 43,000,000 10,000,000 -6,000,000 10,000,000 61,000,000             
      income taxes payable
    		-14,000,000 22,000,000 34,000,000 54,000,000 11,000,000 -73,000,000 38,000,000 -12,000,000 4,000,000 -88,000,000 56,000,000 45,000,000 -33,000,000 -40,000,000 14,000,000 26,000,000 1,000,000 8,000,000 -1,000,000 -3,000,000 7,000,000 -9,000,000 10,000,000 -5,000,000 -3,000,000 -18,000,000 10,000,000 85,000,000 -29,000,000 10,000,000 115,000,000 -5,000,000            
      income taxes receivable
    		                                           
      other assets and liabilities
    		15,000,000 -65,000,000 68,000,000 -49,000,000 14,000,000 -45,000,000 -33,000,000 27,000,000 36,000,000 -6,000,000 36,000,000 75,000,000 -7,000,000 -67,000,000 -37,000,000 -65,000,000 27,000,000 -19,000,000 18,000,000 1,000,000 40,000,000 -20,000,000 13,000,000 -13,000,000 18,000,000 -33,000,000 39,000,000 8,000,000 14,000,000   -96,000,000 47,000,000 -27,000,000 14,000,000 -23,000,000 -23,000,000 -4,000,000 7,000,000 -54,000,000 32,000,000 -46,000,000 -13,000,000 
      net cash from operating activities
    		322,000,000 484,000,000 378,000,000 359,000,000 255,000,000 110,000,000 328,000,000 378,000,000 241,000,000 423,000,000 366,000,000 398,000,000 224,000,000 298,000,000 224,000,000 368,000,000 257,000,000 402,000,000 295,000,000 338,000,000 183,000,000 298,000,000 197,000,000 263,000,000 274,000,000 221,000,000 240,000,000 235,000,000 38,000,000 111,000,000 171,000,000 64,000,000 98,000,000 49,000,000 102,000,000 139,000,000 68,000,000 117,000,000 92,000,000 81,000,000 135,000,000 68,000,000 92,000,000 
      capex
    		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
      free cash flows
    		322,000,000 484,000,000 378,000,000 359,000,000 255,000,000 110,000,000 328,000,000 378,000,000 241,000,000 423,000,000 366,000,000 398,000,000 224,000,000 298,000,000 224,000,000 368,000,000 257,000,000 402,000,000 295,000,000 338,000,000 183,000,000 298,000,000 197,000,000 263,000,000 274,000,000 221,000,000 240,000,000 235,000,000 38,000,000 111,000,000 171,000,000 64,000,000 98,000,000 49,000,000 102,000,000 139,000,000 68,000,000 117,000,000 92,000,000 81,000,000 135,000,000 68,000,000 92,000,000 
      cash flows from investing activities:
    		                                           
      investments in property, plant and equipment
    		-31,000,000 -27,000,000 -32,000,000 -38,000,000 -33,000,000 -36,000,000 -47,000,000 -38,000,000 -45,000,000 -53,000,000 -60,000,000 -58,000,000 -32,000,000 -53,000,000 -42,000,000 -73,000,000 -40,000,000 -33,000,000 -28,000,000 -30,000,000 -32,000,000 -23,000,000 -32,000,000  -30,000,000 -29,000,000 -31,000,000  -40,000,000 -34,000,000 -24,000,000  -21,000,000 -17,000,000 -16,000,000  -14,000,000 -28,000,000 -34,000,000  -35,000,000 -16,000,000 -15,000,000 
      acquisitions of businesses and intangible assets, net of cash acquired
    		0                                           
      other investing activities
    		0 -3,000,000 -1,000,000 12,000,000 0 5,000,000 3,000,000         0        1,000,000 0                   
      net cash from investing activities
    		-31,000,000 -33,000,000 -33,000,000 -38,000,000 -150,000,000 -120,000,000 -511,000,000 -38,000,000 -45,000,000 -145,000,000 -60,000,000 -61,000,000 -48,000,000 -93,000,000 -49,000,000 -115,000,000 -41,000,000 -73,000,000 -124,000,000 -63,000,000 -351,000,000 -23,000,000 -5,000,000 -27,000,000 -120,000,000 -20,000,000 -29,000,000 -19,000,000 -48,000,000 -22,000,000 -27,000,000 -76,000,000 -4,000,000 -1,634,000,000 -8,000,000 -14,000,000 -14,000,000 -38,000,000 -24,000,000 -599,000,000 -42,000,000 -16,000,000 -14,000,000 
      cash flows from financing activities:
    		                                           
      proceeds from issuance of common stock under employee stock plans
    		32,000,000 0 31,000,000 1,000,000 32,000,000 1,000,000 32,000,000 0 34,000,000 0 33,000,000 0 32,000,000 0 31,000,000 0 30,000,000 1,000,000 28,000,000 1,000,000 31,000,000 0 26,000,000  26,000,000 9,000,000 30,000,000  29,000,000 9,000,000 24,000,000  30,000,000           
      payment of taxes related to net share settlement of equity awards
    		-9,000,000 0 -29,000,000 0 -3,000,000 0 -28,000,000 0 -2,000,000 -1,000,000 -46,000,000 0 0 -2,000,000 -72,000,000 0 -2,000,000 -2,000,000 -49,000,000 -1,000,000 -2,000,000 -1,000,000 -49,000,000 0 -2,000,000 -1,000,000 -23,000,000 0 -2,000,000 -1,000,000 -15,000,000             
      proceeds from issuance of long-term debt
    		0                               0 0           
      acquisition of non-controlling interests
    		   0 0 0 -458,000,000                                     
      treasury stock repurchases, including excise tax payments
    		-50,000,000                                           
      debt issuance costs
    		-1,000,000                                           
      repayment of debt
    		   -600,000,000 0                                       
      other financing activities
    		  -1,000,000 6,000,000 -11,000,000 -4,000,000 -1,000,000 -2,000,000 0 0 -1,000,000     -1,000,000                            
      net cash from financing activities
    		-28,000,000 589,000,000 -74,000,000 -160,000,000 -132,000,000 -73,000,000 -548,000,000 -428,000,000 -119,000,000 -1,000,000 -139,000,000 -127,000,000 -207,000,000 -280,000,000 -247,000,000 -354,000,000 -53,000,000 -221,000,000 -43,000,000  22,000,000 -121,000,000 -99,000,000        9,000,000  -208,000,000 1,669,000,000 21,000,000  -9,000,000 -41,000,000 25,000,000  16,000,000 -45,000,000 7,000,000 
      effect of exchange rate movements
    		-1,000,000 18,000,000 -8,000,000 4,000,000   8,000,000 -12,000,000 -3,000,000 -7,000,000 20,000,000 -16,000,000 -6,000,000 -17,000,000 -4,000,000 -1,000,000 -2,000,000 -2,000,000 8,000,000 4,000,000 6,000,000   -1,000,000 -1,000,000 -2,000,000 7,000,000 -6,000,000 -7,000,000 -5,000,000 9,000,000 -1,000,000 4,000,000 3,000,000 -2,000,000 -6,000,000 -1,000,000 10,000,000 -4,000,000 -2,000,000 -3,000,000 0 -8,000,000 
      net increase in cash, cash equivalents, and restricted cash
    		262,000,000 1,058,000,000 263,000,000 165,000,000 -25,000,000 -91,000,000 -723,000,000 -100,000,000 74,000,000 270,000,000 187,000,000 194,000,000 -37,000,000 -92,000,000 -76,000,000 -102,000,000 161,000,000 106,000,000 136,000,000 64,000,000 -140,000,000 150,000,000 93,000,000 204,000,000 116,000,000 178,000,000 185,000,000                 
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 1,814,000,000  0 0 2,488,000,000  0 0 2,057,000,000  0 0 2,068,000,000  0 0 1,767,000,000  0 0 1,600,000,000  0 0 917,000,000                 
      cash, cash equivalents, and restricted cash at end of period
    		262,000,000 1,058,000,000 2,077,000,000  -25,000,000 -91,000,000 1,765,000,000  74,000,000 270,000,000 2,244,000,000  -37,000,000 -92,000,000 1,992,000,000  161,000,000 106,000,000 1,903,000,000  -140,000,000 150,000,000 1,693,000,000  116,000,000 178,000,000 1,102,000,000                 
      supplemental cash flow information:
    		                                           
      interest payments
    		0   37,000,000 0   38,000,000 0   38,000,000 0   38,000,000 0                           
      income tax paid
    		30,000,000 35,000,000 9,000,000 16,000,000 -16,000,000 134,000,000 12,000,000 75,000,000 88,000,000 166,000,000 14,000,000 34,000,000 35,000,000 110,000,000 12,000,000 30,000,000 45,000,000                           
      investments in property, plant and equipment included in accounts payable
    		5,000,000 1,000,000 13,000,000 2,000,000 3,000,000 -1,000,000 15,000,000 7,000,000 0 -1,000,000 24,000,000 8,000,000 4,000,000 -15,000,000 34,000,000 -5,000,000                            
      treasury stock repurchases
    		  -75,000,000  -150,000,000 -46,000,000 -93,000,000 -426,000,000 -151,000,000 0 -125,000,000 -126,000,000 -239,000,000 -278,000,000 -206,000,000 -353,000,000 -80,000,000 -220,000,000 -20,000,000 -215,000,000 0 -120,000,000 -76,000,000 -29,000,000 -61,000,000 -29,000,000 -40,000,000 -40,000,000 -52,000,000       0 -22,000,000       
      interest rate swap agreement termination proceeds
    		       0 0                                   
      prepaid assets
    		   39,000,000 -6,000,000 -10,000,000 -9,000,000 40,000,000 -6,000,000 -17,000,000 -10,000,000                                 
      tax receivables
    		                                           
      proceeds from government incentives
    		                                           
      purchase of investments
    		       0 0   -3,000,000 0                           0    
      cash, cash equivalents, and restricted cash at beginning of year
    		                                           
      cash, cash equivalents, and restricted cash at end of year
    		                                           
      other non-cash income
    		    0    2,000,000    8,000,000 17,000,000 5,000,000  0 0 7,000,000  0 -11,000,000 1,000,000                     
      long-term tax receivable
    		                                           
      acquisition of businesses and intangible assets, net of cash acquired
    		    -117,000,000 -78,000,000 -478,000,000  0    -16,000,000 -10,000,000 -7,000,000  0 -40,000,000 -96,000,000  -319,000,000 0 -5,000,000      -8,000,000 0 -3,000,000  -20,000,000    0       
      retirement and post-retirement benefits
    		      -2,000,000 -1,000,000 -3,000,000 -1,000,000 -3,000,000 2,000,000 -7,000,000 -5,000,000 -9,000,000 2,000,000 1,000,000 5,000,000 -1,000,000 -99,000,000 -3,000,000 -3,000,000 -3,000,000 -4,000,000 -10,000,000 -11,000,000 -12,000,000 -11,000,000 -94,000,000 -10,000,000 -12,000,000 63,000,000 -4,000,000 -3,000,000 -71,000,000  -10,000,000 -9,000,000 -11,000,000 -9,000,000 -8,000,000   
      proceeds from sale and maturities of investments
    		      11,000,000                                     
      loss on settlement of pension plan
    		               0 0                           
      unrealized gain on investments in equity securities
    		                                           
      changes in assets and liabilities:
    		                                           
      gain on insurance proceeds received for damage to property, plant and equipment
    		                   0 0 0 -32,000,000                     
      prepaid expenses
    		                                           
      insurance proceeds received for damage to property, plant and equipment
    		                   0 0 0 32,000,000                     
      payment of acquisition-related contingent consideration
    		               0 0 0 -2,000,000                         
      proceeds from sale of investments
    		                        0        38,000,000        0 0 1,000,000 
      gain on sale of assets and divestitures
    		                                           
      goodwill impairment
    		                                           
      proceeds from the sale of assets and divestitures
    		                                           
      proceeds from short-term borrowings
    		                           0 0   42,000,000 0           
      repayment of debt and credit facility
    		                           0 0               
      net cash provided used in financing activities
    		                                           
      proceeds from divestiture
    		                        0 0 2,000,000  0               
      debt issuance expense
    		                               0 0           
      deferred tax benefit
    		                         10,000,000 -12,000,000  10,000,000               
      excess and obsolete inventory related charges
    		                               4,000,000 6,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 8,000,000 5,000,000 6,000,000 7,000,000 10,000,000 
      pension curtailment and settlement gain
    		                                           
      other non-cash expenses
    		                           6,000,000 4,000,000 3,000,000 2,000,000  0    2,000,000     2,000,000 -1,000,000 
      purchases of property, plant and equipment
    		                                           
      proceeds from the sale of investments
    		                                           
      issuance of common stock under employee stock plans
    		                                  19,000,000 1,000,000 18,000,000 0 24,000,000 3,000,000 15,000,000 4,000,000 4,000,000 
      issuance of common stock under public offering
    		                                           
      net cash provided by/(used in) financing activities
    		                                           
      gain on divestiture
    		                        0 0 -1,000,000                 
      proceeds from credit facility
    		                                           
      net cash used by financing activities
    		                                           
      pension curtailment and settlement loss
    		                          2,000,000                 
      net unrealized gains on equity investments
    		                          -5,000,000                 
      proceeds from revolving credit facility
    		                              40,000,000             
      repayment of revolving credit facility
    		                              -40,000,000             
      net cash provided (used) by financing activities
    		                          -33,000,000  -25,000,000               
      issuance of common stock under public offerings
    		                                           
      net increase in cash and cash equivalents
    		                           171,000,000 -42,000,000 -196,000,000 162,000,000  -110,000,000 87,000,000 113,000,000  44,000,000 48,000,000 89,000,000  106,000,000 7,000,000 77,000,000 
      cash and cash equivalents at beginning of year
    		                                           
      cash and cash equivalents at end of year
    		                                           
      gain on sale of assets and divestiture
    		                            0               
      asset impairment
    		                               0 0           
      pension curtailment and settlement gains
    		                                           
      proceeds from sale of property, plant and equipment
    		                                           
      proceeds from issuance of common stock under public offering
    		                                0           
      payment of debt issuance costs
    		                                0           
      cash and cash equivalents at beginning of period
    		                            0 0 818,000,000  0 0 783,000,000  0 0 483,000,000  0 0 810,000,000 
      cash and cash equivalents at end of period
    		                            -42,000,000 -196,000,000 980,000,000  -110,000,000 87,000,000 896,000,000  44,000,000 48,000,000 572,000,000  106,000,000 7,000,000 887,000,000 
      depreciation and amortization
    		                             79,000,000 78,000,000 72,000,000 80,000,000 41,000,000 32,000,000 33,000,000 34,000,000 34,000,000 33,000,000 30,000,000 23,000,000 23,000,000 23,000,000 
      change in restricted cash and cash equivalents
    		                                           
      gain on sale of land
    		                               0 0 0 -8,000,000 0 0 0 -10,000,000     
      proceeds from sale of land
    		                                0 0 8,000,000  0 0 10,000,000     
      excess tax (benefit) deficiency from share-based plans
    		                               1,000,000            
      payment (to)/from agilent
    		                                           
      proceeds from the sale of property, plant and equipment
    		                                           
      excess tax benefit (deficiency) from share-based plans
    		                               -1,000,000            
      return of capital to agilent
    		                                       0 0   
      net increase/(decrease) in cash and cash equivalents
    		                                           
      deferred taxes
    		                                -30,000,000 -53,000,000 40,000,000  2,000,000 -1,000,000 4,000,000 -178,000,000 2,000,000 14,000,000 -1,000,000 
      excess tax benefit from share-based plans
    		                                 0 -2,000,000    -1,000,000 8,000,000 -1,000,000 0 -3,000,000 
      income tax payable
    		                                 8,000,000 -15,000,000  1,000,000 0 2,000,000     
      excess tax (benefit) deficiency from share based plans
    		                                           
      income and other taxes payable
    		                                           
      retirement and post-retirement benefits liability
    		                                           
      issuance of senior notes
    		                                           
      proceeds from short term borrowings
    		                                           
      repayment of debts and credit facility
    		                                           
      net transfers from agilent
    		                                           
      excess tax loss (benefit) from share-based plans
    		                                           
      payment to agilent
    		                                        0 -14,000,000 -14,000,000 
      excess tax benefit (loss) from share-based plans
    		                                           
      cash paid during the period for:
    		                                           
      interest
    		                                    0    0   
      income taxes, net of refunds
    		                                    9,000,000 0 8,000,000  13,000,000   
      excess tax benefit from share based plans
    		                                           
      asset impairment charges
    		                                           
      change in restricted cash, cash equivalents and investments
    		                                           
      other
    		                                           
      net transfers from/(to) agilent
    		                                           
      net transfers to agilent
    		                                           
      excess tax benefit on share based plans
    		                                           
      excess and obsolete inventory
    		                                           
      related party
    		                                           
      net transfers from (to) agilent
    		                                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.